QuickView for MD-2-related lipid-recognition domain (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
2. The Immunological Genome Project - Immune cell lineage differentiation and maturation
3. Hippocampus, cortex and cerebellum in 5 Alzheimer's disease mouse models - a time course study
4. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
5. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens

There were no matches for MD-2-related lipid-recognition domain

1. Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease
2. Anthocyanins as Dementia Prevention?
3. Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine
4. Sodium Butyrate For Improving Cognitive Function In Schizophrenia
5. Brexpiprazole Treatment for Bipolar I Depression